A novel roadmap connecting the 1H-MRS total choline resonance to all hallmarks of cancer following targeted therapy

Abstract This review describes a cellular adaptive stress signalling roadmap connecting the 1H magnetic resonance spectroscopy (MRS) total choline peak at 3.2 ppm (tCho) to cancer response after targeted therapy (TT). Recent research on cell signalling, tCho metabolism, and TT of cancer has been ret...

Full description

Bibliographic Details
Main Authors: Egidio Iorio, Franca Podo, Martin O. Leach, Jason Koutcher, Francis G. Blankenberg, Joseph F. Norfray
Format: Article
Language:English
Published: SpringerOpen 2021-01-01
Series:European Radiology Experimental
Subjects:
Online Access:https://doi.org/10.1186/s41747-020-00192-z
_version_ 1828242036295204864
author Egidio Iorio
Franca Podo
Martin O. Leach
Jason Koutcher
Francis G. Blankenberg
Joseph F. Norfray
author_facet Egidio Iorio
Franca Podo
Martin O. Leach
Jason Koutcher
Francis G. Blankenberg
Joseph F. Norfray
author_sort Egidio Iorio
collection DOAJ
description Abstract This review describes a cellular adaptive stress signalling roadmap connecting the 1H magnetic resonance spectroscopy (MRS) total choline peak at 3.2 ppm (tCho) to cancer response after targeted therapy (TT). Recent research on cell signalling, tCho metabolism, and TT of cancer has been retrospectively re-examined. Signalling research describes how the unfolded protein response (UPR), a major stress signalling network, transduces, regulates, and rewires the total membrane turnover in different cancer hallmarks after a TT stress. In particular, the UPR signalling maintains or increases total membrane turnover in all pro-survival hallmarks, whilst dramatically decreases turnover during apoptosis, a pro-death hallmark. Recent research depicts the TT-induced stress as a crucial event responsible for interrupting UPR pro-survival pathways, leading to an UPR-mediated cell death. The 1H-MRS tCho resonance represents the total mobile precursors and products during the enzymatic modification of phosphatidylcholine membrane abundance. The tCho profile represents a biomarker that noninvasively monitors TT-induced enzymatic changes in total membrane turnover in a wide variety of existing and new anticancer treatments targeting specific layers of the UPR signalling network. Our overview strongly suggests further evaluating and validating the 1H-MRS tCho peak as a powerful noninvasive imaging biomarker of cancer response in TT clinical trials.
first_indexed 2024-04-12T22:08:40Z
format Article
id doaj.art-7eab32bd967a475aa537574c96e0a0eb
institution Directory Open Access Journal
issn 2509-9280
language English
last_indexed 2024-04-12T22:08:40Z
publishDate 2021-01-01
publisher SpringerOpen
record_format Article
series European Radiology Experimental
spelling doaj.art-7eab32bd967a475aa537574c96e0a0eb2022-12-22T03:14:50ZengSpringerOpenEuropean Radiology Experimental2509-92802021-01-015111410.1186/s41747-020-00192-zA novel roadmap connecting the 1H-MRS total choline resonance to all hallmarks of cancer following targeted therapyEgidio Iorio0Franca Podo1Martin O. Leach2Jason Koutcher3Francis G. Blankenberg4Joseph F. Norfray5High Resolution NMR Unit-Core Facilities, Istituto Superiore di Sanità, Viale Regina ElenaHigh Resolution NMR Unit-Core Facilities, Istituto Superiore di Sanità, Viale Regina ElenaMRI Unit, Royal Marsden HospitalDepartment of Medicine, Memorial Sloan Kettering Cancer CenterStanford University/MIPSEmeritus, Chicago Northside MRI CenterAbstract This review describes a cellular adaptive stress signalling roadmap connecting the 1H magnetic resonance spectroscopy (MRS) total choline peak at 3.2 ppm (tCho) to cancer response after targeted therapy (TT). Recent research on cell signalling, tCho metabolism, and TT of cancer has been retrospectively re-examined. Signalling research describes how the unfolded protein response (UPR), a major stress signalling network, transduces, regulates, and rewires the total membrane turnover in different cancer hallmarks after a TT stress. In particular, the UPR signalling maintains or increases total membrane turnover in all pro-survival hallmarks, whilst dramatically decreases turnover during apoptosis, a pro-death hallmark. Recent research depicts the TT-induced stress as a crucial event responsible for interrupting UPR pro-survival pathways, leading to an UPR-mediated cell death. The 1H-MRS tCho resonance represents the total mobile precursors and products during the enzymatic modification of phosphatidylcholine membrane abundance. The tCho profile represents a biomarker that noninvasively monitors TT-induced enzymatic changes in total membrane turnover in a wide variety of existing and new anticancer treatments targeting specific layers of the UPR signalling network. Our overview strongly suggests further evaluating and validating the 1H-MRS tCho peak as a powerful noninvasive imaging biomarker of cancer response in TT clinical trials.https://doi.org/10.1186/s41747-020-00192-zBiomarkersCholineMagnetic resonance spectroscopyNeoplasmsUnfolded protein response
spellingShingle Egidio Iorio
Franca Podo
Martin O. Leach
Jason Koutcher
Francis G. Blankenberg
Joseph F. Norfray
A novel roadmap connecting the 1H-MRS total choline resonance to all hallmarks of cancer following targeted therapy
European Radiology Experimental
Biomarkers
Choline
Magnetic resonance spectroscopy
Neoplasms
Unfolded protein response
title A novel roadmap connecting the 1H-MRS total choline resonance to all hallmarks of cancer following targeted therapy
title_full A novel roadmap connecting the 1H-MRS total choline resonance to all hallmarks of cancer following targeted therapy
title_fullStr A novel roadmap connecting the 1H-MRS total choline resonance to all hallmarks of cancer following targeted therapy
title_full_unstemmed A novel roadmap connecting the 1H-MRS total choline resonance to all hallmarks of cancer following targeted therapy
title_short A novel roadmap connecting the 1H-MRS total choline resonance to all hallmarks of cancer following targeted therapy
title_sort novel roadmap connecting the 1h mrs total choline resonance to all hallmarks of cancer following targeted therapy
topic Biomarkers
Choline
Magnetic resonance spectroscopy
Neoplasms
Unfolded protein response
url https://doi.org/10.1186/s41747-020-00192-z
work_keys_str_mv AT egidioiorio anovelroadmapconnectingthe1hmrstotalcholineresonancetoallhallmarksofcancerfollowingtargetedtherapy
AT francapodo anovelroadmapconnectingthe1hmrstotalcholineresonancetoallhallmarksofcancerfollowingtargetedtherapy
AT martinoleach anovelroadmapconnectingthe1hmrstotalcholineresonancetoallhallmarksofcancerfollowingtargetedtherapy
AT jasonkoutcher anovelroadmapconnectingthe1hmrstotalcholineresonancetoallhallmarksofcancerfollowingtargetedtherapy
AT francisgblankenberg anovelroadmapconnectingthe1hmrstotalcholineresonancetoallhallmarksofcancerfollowingtargetedtherapy
AT josephfnorfray anovelroadmapconnectingthe1hmrstotalcholineresonancetoallhallmarksofcancerfollowingtargetedtherapy
AT egidioiorio novelroadmapconnectingthe1hmrstotalcholineresonancetoallhallmarksofcancerfollowingtargetedtherapy
AT francapodo novelroadmapconnectingthe1hmrstotalcholineresonancetoallhallmarksofcancerfollowingtargetedtherapy
AT martinoleach novelroadmapconnectingthe1hmrstotalcholineresonancetoallhallmarksofcancerfollowingtargetedtherapy
AT jasonkoutcher novelroadmapconnectingthe1hmrstotalcholineresonancetoallhallmarksofcancerfollowingtargetedtherapy
AT francisgblankenberg novelroadmapconnectingthe1hmrstotalcholineresonancetoallhallmarksofcancerfollowingtargetedtherapy
AT josephfnorfray novelroadmapconnectingthe1hmrstotalcholineresonancetoallhallmarksofcancerfollowingtargetedtherapy